Global Rise in Delayed Childbearing and Infertility Drives Demand for Cross-Border Fertility Care
Asian Case Studies Highlight How Regulation, Cost, and Access Are Shaping International Family Choices TAIPEI, June 6, 2026 /PRNewswire/ -- Delayed marriage, postponed childbearing, and infertility continue to draw global attention as more individuals and couples seek reproductive care beyond their home countries. As the average age of parenthood rises, differences...
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass and preventing post-treatment weight rebound. NEW ORLEANS, June 6, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that a late-breaking abstract on LiCO-saUcp1,...
SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 6, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech), a global leader in biotechnology solutions, today announced the launch of SYNMUE™, a clinically validated probiotic featuring Lactiplantibacillus plantarum LP28, designed to target immune aging, also known as immunosenescence. The company will showcase...
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
NANJING, China, June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion gene is typically formed by the combination of an NTRK gene containing a kinase domain and its fusion partner gene. To date, more than 229 fusion partner genes have been discovered, giving...
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Fintech RedotPay unveiled its...
Pinnacle Food Group Limited Appoints Dr. Yunhao Chen as Chief Financial Officer
VANCOUVER, BC, June 5, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI) (the "Company"), today announced the dismissal of Wencai Pan as Chief Financial Officer and appointment of Dr. Yunhao Chen as Chief Financial Officer of the Company, both effective June 1, 2026. Dr. Chen has extensive public company...
Colgate Optic White® x Chicha San Chen Proudly Debut the “Dental-Grade Teeth Whitening Lab”
Spearheading the Teeth Whitening Trend of "Bright Smile with A Sip of Fine Tea" with the Exclusive Limited-Edition Drink "Optic White Green Tea with Mist Foam" Unlock the Dental-Grade Bright Smile with Hydrogen Peroxide (HP) - Hong Kong Dentists' Most Preferred Whitening Ingredient^ HONG KONG, June 5, 2026 /PRNewswire/ -- Savor your daily cup of artisanal tea and...
UTGL Donates HK$650,000 to Advance Anti-Aging, Cardiovascular Health and Healthy Longevity Through Corporate Social Responsibility and Clinical Research
HONG KONG, June 5, 2026 /PRNewswire/ -- UniTrust Global Limited | UTGL announced a donation of HK$650,000 to Prime Healthcare Medical Services Limited in support of a clinical study on Enhanced External Counterpulsation (EECP). The donation reflects UTGL's long-term corporate vision of supporting local medical research, improving human health and well-being, and exploring cutting-edge anti-aging and regenerative technologies through...
Aphranel® Marks First Anniversary with EU MDR Certification, Arc™ Launch, and Over 150,000 Syringes Delivered
SHANGHAI, June 5, 2026 /PRNewswire/ -- On May 20, 2026, Aphranel® celebrated its first anniversary at the Waldorf Astoria Shanghai on the Bund, marking a major milestone in the brand's international presence in regenerative aesthetics. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" Highlights from the Aphranel® First Anniversary Summit in Shanghai. jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2994914/726d3a2a572ee4705a23eecfc510b32b_raw.mp4', image: 'https://mma.prnasia.com/media2/2994914/726d3a2a572ee4705a23eecfc510b32b_raw.mp4?p=medium', autostart:'false', stretching...
Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease
SHANGHAI, June 5, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative antibody drug 9MW5211 has received approval from the National Medical Products Administration (NMPA) to conduct clinical trials for inflammatory bowel disease (IBD). 9MW5211 is the first candidate drug for its target to enter clinical...
